Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
28 May 2004Next earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Fri, 24 May 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
NBSE Latest News
NeuBase Therapeutics (NASDAQ: NBSE ) stock is falling on Tuesday after the company announced details for an upcoming special shareholder meeting. The big news here is that NeuBase Therapeutics is seeking shareholder approval for the liquidation and dissolution of the company.
With NeuBase (NBSE) exploring strategic alternatives to the company, Symetryx joins the company's shareholder base and urges the board to issue a unique $1 per share dividend.
NeuBase Therapeutics (NASDAQ: NBSE ) stock is taking off on Wednesday despite a lack of news from the preclinical biopharmaceutical company. There are no new press releases from NeuBase Therapeutics or filings with the Securities and Exchange Commission (SEC) that explain why the stock is up today.
What type of business is NeuBase Therapeutics?
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its lead programs include NT0100, a PATrOL enabled anti-gene for Huntington's disease; NT0200, a PATrOL enabled anti-gene for myotonic dystrophy type 1; NT0300, a PATrOL-enabled therapeutic treatment to target the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.
What sector is NeuBase Therapeutics in?
NeuBase Therapeutics is in the Healthcare sector
What industry is NeuBase Therapeutics in?
NeuBase Therapeutics is in the Biotechnology industry
What country is NeuBase Therapeutics from?
NeuBase Therapeutics is headquartered in United States
When did NeuBase Therapeutics go public?
NeuBase Therapeutics initial public offering (IPO) was on 28 May 2004
What is NeuBase Therapeutics website?
https://www.neubasetherapeutics.com
Is NeuBase Therapeutics in the S&P 500?
No, NeuBase Therapeutics is not included in the S&P 500 index
Is NeuBase Therapeutics in the NASDAQ 100?
No, NeuBase Therapeutics is not included in the NASDAQ 100 index
Is NeuBase Therapeutics in the Dow Jones?
No, NeuBase Therapeutics is not included in the Dow Jones index
When does NeuBase Therapeutics report earnings?
Next earnings report date is not announced yet